A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...

To the research team working to save him, KJ Muldoon was first known only as Patient Eta. But within months, KJ’s name — and ...

The inaugural competition surprisingly awarded two $100,000 grand prizes to address challenges in defining robust benchmarks for complex biology.

A collaborative effort by the Formosa-Jordan lab from the Max Planck Institute for Plant Breeding Research in Cologne, ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Kian Sadeghi, the 25-year-old founder and CEO at Nucleus Genomics, tells "CBS Mornings" that parents have every right to select the qualities and traits they desire in their child.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ST-503, an investigational ...

Explore the growing AI supercomputer market, projected to rise from 3.1 billion USD in 2025 to 15.4 billion USD by 2034.

Stay updated on the hottest topics, news, and current events, from the Formula 1 Qatar 2025, Lantern Festival, celebrities ...

The field of genomic medicine has experienced tremendous progress with the advent of next-generation sequencing (NGS), which ...